Tetiana V. Kolomiichenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tetiana V. Kolomiichenko has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Oleksii Zhdanovych
Shupyk National Healthcare University of Ukraine, Kyiv
11 shared publications - Ruslan Savchuk
Shupyk National Healthcare University of Ukraine, Kyiv
10 shared publications - Viacheslav Kaminskiy
Shupyk National Healthcare University of Ukraine, Kyiv
7 shared publications - Vorobey Ludmila
Shupyk National Healthcare University of Ukraine, Kyiv
5 shared publications - Anatoliy V. Kaminskiy
Shupyk National Healthcare University of Ukraine, Kyiv
3 shared publications - Oleksandra Hryhorivna Boichuk
Ivano-Frankivsk National Medical University, Department of Obstetrics and Gynecology of Postgraduate Education, Ivano-Frankivsk, Ukraine
3 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Association of Obstetricians and Gynaecologists of Ukraine in Scientific digest of association of obstetricians and gynecologists of Ukraine
- No. 1(57),p. 31-36
PROGNOSTIC INDEX OF PERINATAL COMPLICATIONS IN PREGNANT WOMEN WITH PTSD
The aim of the study was to develop a prognostic index for perinatal complications in pregnant women with post-traumatic stress disorder (PTSD). Materials and methods. To construct the prognostic index, a comparative analysis of the frequency of the studied indicators was conducted across two groups of pregnant women with PTSD: Group 1 (with perinatal complications, n = 58) and Group 2 (without complications, n = 92). The logarithmic transformation of the odds ratio (ln(OR)) was calculated. The discriminative ability of the prognostic index was evaluated using ROC analysis. Results. The prognostic model comprises four levels: I. Background prognosis; II. Functional prog nosis; III. Endogenous (neuroendocrine) prognosis; IV. Integral index. ROC analysis demonstrated an increase in the prognostic capacity of the indices from level I to level III. The integral prognostic index demonstrated the highest discriminative performance (AUC = 0.86, 95% CI [0.80–0.92]) at a threshold of 0.53 of the maximum score. Conclusion. The integral prognostic index provides a comprehensive quantitative assessment of perinatal risk and can serve as a tool for stratifying pregnant women, personalizing medical care, and planning preventive measures.
- 29 September 2026
- Published by Association of Obstetricians and Gynaecologists of Ukraine in Scientific digest of association of obstetricians and gynecologists of Ukraine
- No. 1(57),p. 31-36
Open AccessPROGNOSTIC INDEX OF PERINATAL COMPLICATIONS IN PREGNANT WOMEN WITH PTSD
The aim of the study was to develop a prognostic index for perinatal complications in pregnant women with post-traumatic stress disorder (PTSD). Materials and methods. To construct the prognostic index, a comparative analysis of the frequency of the studied indicators was conducted across two groups of pregnant women with PTSD: Group 1 (with perinatal complications, n = 58) and Group 2 (without complications, n = 92). The logarithmic transformation of the odds ratio (ln(OR)) was calculated. The discriminative ability of the prognostic index was evaluated using ROC analysis. Results. The prognostic model comprises four levels: I. Background prognosis; II. Functional prog nosis; III. Endogenous (neuroendocrine) prognosis; IV. Integral index. ROC analysis demonstrated an increase in the prognostic capacity of the indices from level I to level III. The integral prognostic index demonstrated the highest discriminative performance (AUC = 0.86, 95% CI [0.80–0.92]) at a threshold of 0.53 of the maximum score. Conclusion. The integral prognostic index provides a comprehensive quantitative assessment of perinatal risk and can serve as a tool for stratifying pregnant women, personalizing medical care, and planning preventive measures.
- Open Access
- 28 May 2026
- Published by Ternopil State Medical University in Актуальні питання педіатрії, акушерства та гінекології
- No. 1,p. 30-34
EVALUATION OF THE REGIONAL PROJECT OF THE MODEL FOR PREDICTION AND PREVENTION OF PERINATAL DISORDERS IN COVID-19 IN THE MOTHER
The aim of the study – to evaluate the model for predicting and preventing adverse perinatal consequences of COVID-19 in the mother in the Ivano-Frankivsk region. Materials and Methods. A SWOT analysis was conducted to assess the model for predicting and preventing adverse perinatal consequences of COVID-19 in the mother in the Ivano-Frankivsk region, taking into account the realities of the regional healthcare system, the stages of the pandemic, resource provision and the specifics of perinatal care. SMART analysis was used to verify and improve the project objectives. Results and Discussion. Conducting a SWOT analysis allowed us to identify the strengths and weaknesses of the project, opportunities and threats, and to recommend for its effective implementation: strengthen integration between medical institutions; launch a pilot registry of pregnant women with COVID-19 in the region; involve local universities in statistical modeling; conduct training for doctors on perinatal risk assessment using modern scales; inform patients about the risks of perinatal complications and the benefits of their prevention. According to the results of the SMART analysis, the goal of the model is realistic, strategically justified and important for the protection of motherhood in conditions of pandemic uncertainty. Conclusions. According to the assessment, the model for predicting and preventing adverse perinatal consequences of COVID-19 in the mother in Ivano-Frankivsk region can be recommended for implementation. The use of SWOT and SMART analysis is an effective tool for assessing and controlling the implementation of medical projects at the regional level.
- 28 May 2026
- Published by Ternopil State Medical University in Актуальні питання педіатрії, акушерства та гінекології
- No. 1,p. 30-34
Open AccessEVALUATION OF THE REGIONAL PROJECT OF THE MODEL FOR PREDICTION AND PREVENTION OF PERINATAL DISORDERS IN COVID-19 IN THE MOTHER
The aim of the study – to evaluate the model for predicting and preventing adverse perinatal consequences of COVID-19 in the mother in the Ivano-Frankivsk region. Materials and Methods. A SWOT analysis was conducted to assess the model for predicting and preventing adverse perinatal consequences of COVID-19 in the mother in the Ivano-Frankivsk region, taking into account the realities of the regional healthcare system, the stages of the pandemic, resource provision and the specifics of perinatal care. SMART analysis was used to verify and improve the project objectives. Results and Discussion. Conducting a SWOT analysis allowed us to identify the strengths and weaknesses of the project, opportunities and threats, and to recommend for its effective implementation: strengthen integration between medical institutions; launch a pilot registry of pregnant women with COVID-19 in the region; involve local universities in statistical modeling; conduct training for doctors on perinatal risk assessment using modern scales; inform patients about the risks of perinatal complications and the benefits of their prevention. According to the results of the SMART analysis, the goal of the model is realistic, strategically justified and important for the protection of motherhood in conditions of pandemic uncertainty. Conclusions. According to the assessment, the model for predicting and preventing adverse perinatal consequences of COVID-19 in the mother in Ivano-Frankivsk region can be recommended for implementation. The use of SWOT and SMART analysis is an effective tool for assessing and controlling the implementation of medical projects at the regional level.
- Open Access
- 31 July 2025
- Published by Professional Event, LLC in Reproductive health of woman
- No. 5,p. 65-71
Analysis of physicians’ experience in providing perinatal care during the COVID-19 pandemic
In pandemic conditions, a survey of doctors can provide important information about their experience, problems and preferences, which will ultimately lead to increased effectiveness of obstetric and perinatal care.The objective: to determine the determinants of doctors’ perception of perinatal care services during the COVID-19 pandemic.Materials and methods. 70 doctors were surveyed using a developed questionnaire for doctors: 30 of them provided perinatal care during the COVID-19 pandemic at the hospital stage (group 1), 40 doctors – at the outpatient level (group 2).Results. The survey of doctors showed that the vast majority (81.4%) of them experienced an increase in workload at the workplace. At the same time, only 10.0% of respondents noted an increase in wages during the pandemic: 16.7% and 5.0% of respondents at the hospital and outpatient stages. Also, the vast majority (78.6%) of doctors observed an increased number of conflict situations, more so at the outpatient stage (82.5% versus 73.3%). The vast majority of respon-dents (91.4%) noted the provision of special conditions for COVID-infected patients in order to prevent the spread of infection: separate outpatient appointment times (22.5%), separate rooms, separate entrance. Distance consultations (by telephone or online) were provided by the majority of doctors at the outpatient stage (62.5%) and a third (36.7%) of doctors at the hospital stage. More than half of the doctors considered the level of information and regulatory support during the pandemic to be insufficient, and this lack was especially acutely felt by outpatient workers (80.0% versus 33.3%, p < 0.05). The hospital stage was significantly better equipped with personal protective equipment: 60.0% of the surveyed doctors assessed its adequacy at 70–100%, while at the outpatient stage only 15.5% of the surveyed doctors chose such an assessment (p < 0.05). Among the most frequent proposals of doctors were: increasing the remuneration of medical personnel during the pandemic (80.0%), improving material and technical support, improving information and operational regulatory support (78.6%), as well as introducing a psychological support service for personnel (71.4%).Conclusions. In general, the provision of perinatal care during the COVID-19 pandemic, according to doctors, was carried out at a relatively sufficient level, however, certain shortcomings were identified, the consideration of which could improve the quality of such care.
- 31 July 2025
- Published by Professional Event, LLC in Reproductive health of woman
- No. 5,p. 65-71
Open AccessAnalysis of physicians’ experience in providing perinatal care during the COVID-19 pandemic
In pandemic conditions, a survey of doctors can provide important information about their experience, problems and preferences, which will ultimately lead to increased effectiveness of obstetric and perinatal care.The objective: to determine the determinants of doctors’ perception of perinatal care services during the COVID-19 pandemic.Materials and methods. 70 doctors were surveyed using a developed questionnaire for doctors: 30 of them provided perinatal care during the COVID-19 pandemic at the hospital stage (group 1), 40 doctors – at the outpatient level (group 2).Results. The survey of doctors showed that the vast majority (81.4%) of them experienced an increase in workload at the workplace. At the same time, only 10.0% of respondents noted an increase in wages during the pandemic: 16.7% and 5.0% of respondents at the hospital and outpatient stages. Also, the vast majority (78.6%) of doctors observed an increased number of conflict situations, more so at the outpatient stage (82.5% versus 73.3%). The vast majority of respon-dents (91.4%) noted the provision of special conditions for COVID-infected patients in order to prevent the spread of infection: separate outpatient appointment times (22.5%), separate rooms, separate entrance. Distance consultations (by telephone or online) were provided by the majority of doctors at the outpatient stage (62.5%) and a third (36.7%) of doctors at the hospital stage. More than half of the doctors considered the level of information and regulatory support during the pandemic to be insufficient, and this lack was especially acutely felt by outpatient workers (80.0% versus 33.3%, p < 0.05). The hospital stage was significantly better equipped with personal protective equipment: 60.0% of the surveyed doctors assessed its adequacy at 70–100%, while at the outpatient stage only 15.5% of the surveyed doctors chose such an assessment (p < 0.05). Among the most frequent proposals of doctors were: increasing the remuneration of medical personnel during the pandemic (80.0%), improving material and technical support, improving information and operational regulatory support (78.6%), as well as introducing a psychological support service for personnel (71.4%).Conclusions. In general, the provision of perinatal care during the COVID-19 pandemic, according to doctors, was carried out at a relatively sufficient level, however, certain shortcomings were identified, the consideration of which could improve the quality of such care.
- 30 July 2025
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2025 (7) , 1220-1230
Effectiveness of using ferning of the dried saliva crystallization to determine the fertile window in women with idiopathic infertility
Aim: To evaluate the effectiveness of determining the fertile window in women with idiopathic infertility based on the results of crystallization of saliva samples obtained using the Ovul portable device with a mobile application by comparing them with the results of urine test strips and folliculometry data.Material and methods: The menstrual cycles of 42 women with idiopathic infertility were analyzed: Group I - 21 women who took drugs to induce ovulation, Group II - 21 women with natural menstrual and ovarian cycles. Ovulation was confirmed or excluded based on the results of the Ovul device, urine test strips, and folliculometry.Results: Although ovulation detection using the Ovul device and urine test strips has 100% specificity, the sensitivity of the device is 97.4%and the accuracy is 97.6% (if the positive result is ovulation or the fertile window), while for urine test strips the sensitivity is 94.9% and the accuracy is 95.2% if we consider a positive result not only to be the same as the day of ovulation according to folliculometry, but also a positive result within the next 72 hours (mainly 12-24).Conclusions: Ovulation detection using the Ovul device is a highly accurate, 100% specific and highly sensitive method that can be used at home, will optimize diagnostics, make it more convenient and cheaper for patients who want to get pregnant or, on the contrary, who are trying to avoid pregnancy.
- 30 July 2025
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2025 (7) , 1220-1230
Effectiveness of using ferning of the dried saliva crystallization to determine the fertile window in women with idiopathic infertility
Aim: To evaluate the effectiveness of determining the fertile window in women with idiopathic infertility based on the results of crystallization of saliva samples obtained using the Ovul portable device with a mobile application by comparing them with the results of urine test strips and folliculometry data.Material and methods: The menstrual cycles of 42 women with idiopathic infertility were analyzed: Group I - 21 women who took drugs to induce ovulation, Group II - 21 women with natural menstrual and ovarian cycles. Ovulation was confirmed or excluded based on the results of the Ovul device, urine test strips, and folliculometry.Results: Although ovulation detection using the Ovul device and urine test strips has 100% specificity, the sensitivity of the device is 97.4%and the accuracy is 97.6% (if the positive result is ovulation or the fertile window), while for urine test strips the sensitivity is 94.9% and the accuracy is 95.2% if we consider a positive result not only to be the same as the day of ovulation according to folliculometry, but also a positive result within the next 72 hours (mainly 12-24).Conclusions: Ovulation detection using the Ovul device is a highly accurate, 100% specific and highly sensitive method that can be used at home, will optimize diagnostics, make it more convenient and cheaper for patients who want to get pregnant or, on the contrary, who are trying to avoid pregnancy.
- Open Access
- 30 June 2025
- Published by Professional Event, LLC in Reproductive health of woman
- No. 4,p. 16-21
Вплив перебігу COVID-19 на перинатальні ускладнення
The studies of the impact of the new global disease – coronavirus disease – on the organism of pregnant women, newborns, infants and children continue, and the pathogenetic mechanisms of such impact remain not fully defined.The objective: to determine the impact of COVID-19 on perinatal complications.Materials and methods. 200 women hospitalized with COVID-19 during pregnancy were examined. Pregnant women were divided into two groups: Group 1 consisted of 50 women with perinatal complications (fetal distress, fetal growth retardation, preterm birth, severe neonatal asphyxia, perinatal death), Group 2 consisted of 150 patients with a physiological course of pregnancy.Results. It was found that in pregnant women with perinatal complications, the course of COVID-19 disease has certain differences compared to patients without perinatal disorders. A significantly higher rate of women with perinatal complications who became ill with COVID-19 in the III trimester of pregnancy was found (80.0 vs 54.0%, respectively, p < 0.05). In Group 1, there were almost 2 times more women who felt sick for 5 to 10 days at the time of hospitalization (34.0 vs 18.0% in Group 2, p < 0.05) and 2.5 times more women who were sick for more than 10 days (18.0 vs 7.3%, respectively, p < 0.05). It is noteworthy that the frequency of severe COVID-19 in pregnant women with perinatal disorders is almost 3 times higher than in women with a physio-logical course of pregnancy (66.0 vs 22.7%, p < 0.05). In Group 1, an increased frequency of all components of the severity of the disease was found by 2 times or more compared to Group 2, in particular pneumonia (70.0 vs 24.7%, p < 0.05), hyperthermia (58.0 vs 21.3%, p < 0.05), which lasted more than 5 days (26.0 vs 6.7%), SpO2 less than 93% (78.0 vs 23.3%, p < 0.05).Conclusions. Manifestations of severe COVID-19 in pregnant women, such as pneumonia, hyperthermia, low saturation, are risk factors for perinatal complications in such women, which requires the development and implementation of a system for predicting and preventing perinatal disorders.
- 30 June 2025
- Published by Professional Event, LLC in Reproductive health of woman
- No. 4,p. 16-21
Open AccessВплив перебігу COVID-19 на перинатальні ускладнення
The studies of the impact of the new global disease – coronavirus disease – on the organism of pregnant women, newborns, infants and children continue, and the pathogenetic mechanisms of such impact remain not fully defined.The objective: to determine the impact of COVID-19 on perinatal complications.Materials and methods. 200 women hospitalized with COVID-19 during pregnancy were examined. Pregnant women were divided into two groups: Group 1 consisted of 50 women with perinatal complications (fetal distress, fetal growth retardation, preterm birth, severe neonatal asphyxia, perinatal death), Group 2 consisted of 150 patients with a physiological course of pregnancy.Results. It was found that in pregnant women with perinatal complications, the course of COVID-19 disease has certain differences compared to patients without perinatal disorders. A significantly higher rate of women with perinatal complications who became ill with COVID-19 in the III trimester of pregnancy was found (80.0 vs 54.0%, respectively, p < 0.05). In Group 1, there were almost 2 times more women who felt sick for 5 to 10 days at the time of hospitalization (34.0 vs 18.0% in Group 2, p < 0.05) and 2.5 times more women who were sick for more than 10 days (18.0 vs 7.3%, respectively, p < 0.05). It is noteworthy that the frequency of severe COVID-19 in pregnant women with perinatal disorders is almost 3 times higher than in women with a physio-logical course of pregnancy (66.0 vs 22.7%, p < 0.05). In Group 1, an increased frequency of all components of the severity of the disease was found by 2 times or more compared to Group 2, in particular pneumonia (70.0 vs 24.7%, p < 0.05), hyperthermia (58.0 vs 21.3%, p < 0.05), which lasted more than 5 days (26.0 vs 6.7%), SpO2 less than 93% (78.0 vs 23.3%, p < 0.05).Conclusions. Manifestations of severe COVID-19 in pregnant women, such as pneumonia, hyperthermia, low saturation, are risk factors for perinatal complications in such women, which requires the development and implementation of a system for predicting and preventing perinatal disorders.
- 28 June 2025
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL HEALTH OF WOMAN
- No. 3(178),p. 5-11
Mathematical model for predicting adverse perinatal outcomes in women with COVID-19
The aim: to create a mathematical model for predicting adverse perinatal outcomes in women with COVID-19. Materials and methods. To build a mathematical prediction model, candidate indicators were selected whose frequency significantly differed in the groups of pregnant women with significant perinatal disorders (group O1, n=50) and without such disorders (group O2, n=150), and odds ratio (OR) calculations were performed. To assess the significance of the indicators in points and assign threshold values, the expert evaluation method, the Delphi method, was used. Results. The most statistically significant indicators for predicting perinatal disorders in pregnant women with COVID-19 are laboratory indicators associated with COVID-19, indicators of disease severity, stress, the presence of anxiety and depression, and endocrine pathology. The constructed model (scale) for predicting perinatal disorders in pregnant women with COVID-19 includes 24 indicators and can be used in 2 stages: 1 - at the prehospital stage and/or at the beginning of hospitalization (9 indicators), 2 - in the dynamics of the disease at the hospital stage (15 indicators). The ease of use (scoring), as well as the established fairly high accuracy (86.7%), sensitivity (87.5%), and specificity (86.4%) of the prediction model, allow us to recommend it for use in clinical practice. Conclusions. The implementation of a model for predicting perinatal disorders in pregnant women with COVID-19 for the purpose of early identification of high-risk patients, their timely hospitalization, and treatment will reduce the incidence of perinatal complications, morbidity, and mortality of the mother and child. The research was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee of the institution mentioned in the paper. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.
- 28 June 2025
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL HEALTH OF WOMAN
- No. 3(178),p. 5-11
Mathematical model for predicting adverse perinatal outcomes in women with COVID-19
The aim: to create a mathematical model for predicting adverse perinatal outcomes in women with COVID-19. Materials and methods. To build a mathematical prediction model, candidate indicators were selected whose frequency significantly differed in the groups of pregnant women with significant perinatal disorders (group O1, n=50) and without such disorders (group O2, n=150), and odds ratio (OR) calculations were performed. To assess the significance of the indicators in points and assign threshold values, the expert evaluation method, the Delphi method, was used. Results. The most statistically significant indicators for predicting perinatal disorders in pregnant women with COVID-19 are laboratory indicators associated with COVID-19, indicators of disease severity, stress, the presence of anxiety and depression, and endocrine pathology. The constructed model (scale) for predicting perinatal disorders in pregnant women with COVID-19 includes 24 indicators and can be used in 2 stages: 1 - at the prehospital stage and/or at the beginning of hospitalization (9 indicators), 2 - in the dynamics of the disease at the hospital stage (15 indicators). The ease of use (scoring), as well as the established fairly high accuracy (86.7%), sensitivity (87.5%), and specificity (86.4%) of the prediction model, allow us to recommend it for use in clinical practice. Conclusions. The implementation of a model for predicting perinatal disorders in pregnant women with COVID-19 for the purpose of early identification of high-risk patients, their timely hospitalization, and treatment will reduce the incidence of perinatal complications, morbidity, and mortality of the mother and child. The research was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee of the institution mentioned in the paper. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.
- Open Access
- 23 May 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 2,p. 33-38
Medical and Social Risk Factors of Perinatal Disorders in Women with COVID-19
The exact mechanisms and possibility of perinatal disorders in women after COVID-19 have not been definitively determined. In particular, the connection of such disorders with medical and social status is not known. The objective: to determine the medical and social risk factors for perinatal disorders in women who had COVID-19 during pregnancy. Materials and methods. The participants of the study were divided into two groups: the main group (MG) consisted of 200 women who were hospitalized with COVID-19 during pregnancy, the control group – 50 patients who did not have COVID-19 or other acute respiratory viral infections during pregnancy. The main group is divided into 2 subgroups: MG-1 – 50 women with adverse perinatal outcomes (perinatal mortality, fetal distress and/or fetal growth retardation, premature birth, fetal severe birth asphyxia), subgroup MG-2 – 150 patients with a physiological course of pregnancy. Indicators of social and economic status, harmful habits, lifestyle parameters, and stress were analyzed. The presence and level of anxiety and depression were determined using the Hospital Anxiety and Depression Scale (HADS). Results. Among the indicators of social and economic status with a negative impact on pregnancy outcomes were: living in the cities (44.0% in subgroup MG-1 vs 30.7% in subgroup MG-2, p < 0.05), higher education (44.0% vs 30.7%, p < 0.05), unregistered marriage (30.0% vs 16.7%, p < 0.05), income per family member less than 5,000 UAH/month (46.0% vs 22.7%, p < 0.05). When analyzing social and domestic characteristics, attention is drawn to the high frequency of alcohol consumption (10.0% vs 3.3%, p < 0.05), sedentary lifestyle (44.0% vs 26.0%, p < 0.05) and an increased stress level (70.0% vs 43.3%, p < 0.05), in particular at work (22.0% vs 11.3%, p < 0.05) and the combination of stress at home and at work (16.0% vs 7.3%, p < 0.05). The patients were characterized by the extremely high level of anxiety (90.0% vs 74.3%, p < 0.05), with a third of patients were diagnosed with clinically significant anxiety (30.0% vs 11.3%, p < 0.05), and higher depression level (28.0% vs 7.3%, p < 0.05). Conclusions. Perinatal disorders in patients who have had COVID-19 during pregnancy are associated with certain changes in medical and social status. Pregnancy management in these women requires analysis of medical and social factors, psychological assessment, timely application of psycho-emotional correction techniques to prevent negative perinatal consequences.
- 23 May 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 2,p. 33-38
Open AccessMedical and Social Risk Factors of Perinatal Disorders in Women with COVID-19
The exact mechanisms and possibility of perinatal disorders in women after COVID-19 have not been definitively determined. In particular, the connection of such disorders with medical and social status is not known. The objective: to determine the medical and social risk factors for perinatal disorders in women who had COVID-19 during pregnancy. Materials and methods. The participants of the study were divided into two groups: the main group (MG) consisted of 200 women who were hospitalized with COVID-19 during pregnancy, the control group – 50 patients who did not have COVID-19 or other acute respiratory viral infections during pregnancy. The main group is divided into 2 subgroups: MG-1 – 50 women with adverse perinatal outcomes (perinatal mortality, fetal distress and/or fetal growth retardation, premature birth, fetal severe birth asphyxia), subgroup MG-2 – 150 patients with a physiological course of pregnancy. Indicators of social and economic status, harmful habits, lifestyle parameters, and stress were analyzed. The presence and level of anxiety and depression were determined using the Hospital Anxiety and Depression Scale (HADS). Results. Among the indicators of social and economic status with a negative impact on pregnancy outcomes were: living in the cities (44.0% in subgroup MG-1 vs 30.7% in subgroup MG-2, p < 0.05), higher education (44.0% vs 30.7%, p < 0.05), unregistered marriage (30.0% vs 16.7%, p < 0.05), income per family member less than 5,000 UAH/month (46.0% vs 22.7%, p < 0.05). When analyzing social and domestic characteristics, attention is drawn to the high frequency of alcohol consumption (10.0% vs 3.3%, p < 0.05), sedentary lifestyle (44.0% vs 26.0%, p < 0.05) and an increased stress level (70.0% vs 43.3%, p < 0.05), in particular at work (22.0% vs 11.3%, p < 0.05) and the combination of stress at home and at work (16.0% vs 7.3%, p < 0.05). The patients were characterized by the extremely high level of anxiety (90.0% vs 74.3%, p < 0.05), with a third of patients were diagnosed with clinically significant anxiety (30.0% vs 11.3%, p < 0.05), and higher depression level (28.0% vs 7.3%, p < 0.05). Conclusions. Perinatal disorders in patients who have had COVID-19 during pregnancy are associated with certain changes in medical and social status. Pregnancy management in these women requires analysis of medical and social factors, psychological assessment, timely application of psycho-emotional correction techniques to prevent negative perinatal consequences.
- Open Access
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- Vol. 15 (2) , 14-19
MODEL FOR PREDICTION AND PREVENTION OF ADVERSE PERINATAL OUTCOMES IN COVID-19 IN WOMEN
Relevance. The task of developing a model for predicting and preventing adverse perinatal outcomes in women with COVID-19 is relevant, which should provide an effective clinical solution taking into account individual and regional characteristics, which will contribute to reducing maternal and perinatal morbidity and mortality. Purpose. To create a tool for early identification of pregnant women with a high risk of complications in case of COVID-19 to reduce maternal and perinatal mortality, prevent adverse perinatal complications (using the example of Ivano-Frankivsk region).Materials and methods. The creation of a model for predicting and preventing adverse perinatal outcomes in case of COVID-19 in women is based on research using the bibliosemantic research method, the method of structural-logical analysis, analytical, statistical and conceptual methods, clinical, anamnestic and laboratory-instrumental methods, and questionnaires. Results. The medical and social justification, principles of formation and expected results of the implementation of the model of prediction and prevention of adverse perinatal consequences of COVID-19 in women are presented. The development and implementation of such a model can be carried out in 5 stages over 3 years: preparatory and analytical (1–2 quarters of the 1st year); creation and testing of a digital model (3–4 quarters of the 1st year); pilot implementation in the region (1–2 quarters of the 2nd year); scaling and integration (3–4 quarters of the 2nd year); effectiveness assessment and continuous improvement (3rd year and beyond). Model components: screening stage (at the primary level); prediction stage (secondary level); response stage (tertiary level); information support and monitoring. Conclusions. The practical implementation of the developed model allows improving the quality of medical care for pregnant women during the pandemic, optimizing the use of healthcare system resources, reducing the incidence of complications and improving perinatal outcomes even in conditions of limited resources. Актуальність. Актуальним є завдання розробки моделі прогнозування і профілактики несприятливих перинатальних наслідків у жінок із COVID-19, яка має забезпечити ефективне клінічне рішення з урахуванням індивідуальних та регіональних особливостей, що сприятиме зниженню материнської і перинатальної захворюваності та смертності. Мета. Створити інструмент для ранньої ідентифікації вагітних із високим ризиком ускладнень у разі COVID-19 для зниження материнської та перинатальної смертності, попередження несприятливих перинатальних ускладнень (на прикладі Івано-Франківської області). Матеріали та методи.Створення моделі прогнозування і профілактики несприятливих перинатальних наслідків при COVID-19 у жінки базується на проведених дослідженнях з використанням бібліосемантичного методу дослідження, метод структурно-логічного аналізу, аналітичний, статистичний та концептуальний методи, клінічні, анамнестичні та лабораторно-інструментальні методи, анкетування. Результати. Наведено медико-соціальне обґрунтування, принципи формування та очікувані результати впровадження моделі прогнозування і профілактики несприятливих перинатальних наслідків при COVID-19 у жінки. Розробка і впровадження такої моделі може здійснюватись у 5 етапів за 3 роки: підготовчо-аналітичний (1–2 квартал 1-го року); створення і тестування цифрової моделі (3–4 квартал 1-го року); пілотне впровадження в регіоні (1–2 квартал 2-го року); масштабування та інтеграція (3–4 квартал 2-го року); оцінка ефективності та постійне вдосконалення (3-й рік рік і далі). Компоненти моделі: етап скринінгу (на первинному рівні); етап прогнозування (вторинний рівень); етап реагування (третинний рівень); інформаційна підтримка та моніторинг. Висновки. Практичне впровадження розробленої моделі дозволяє покращити якість медичної допомоги вагітним у період пандемії, оптимізувати використання ресурсів системи охорони здоров’я, знизити частоту ускладнень та підвищити перинатальні результати навіть в умовах обмежених ресурсів.
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- Vol. 15 (2) , 14-19
Open AccessMODEL FOR PREDICTION AND PREVENTION OF ADVERSE PERINATAL OUTCOMES IN COVID-19 IN WOMEN
Relevance. The task of developing a model for predicting and preventing adverse perinatal outcomes in women with COVID-19 is relevant, which should provide an effective clinical solution taking into account individual and regional characteristics, which will contribute to reducing maternal and perinatal morbidity and mortality. Purpose. To create a tool for early identification of pregnant women with a high risk of complications in case of COVID-19 to reduce maternal and perinatal mortality, prevent adverse perinatal complications (using the example of Ivano-Frankivsk region).Materials and methods. The creation of a model for predicting and preventing adverse perinatal outcomes in case of COVID-19 in women is based on research using the bibliosemantic research method, the method of structural-logical analysis, analytical, statistical and conceptual methods, clinical, anamnestic and laboratory-instrumental methods, and questionnaires. Results. The medical and social justification, principles of formation and expected results of the implementation of the model of prediction and prevention of adverse perinatal consequences of COVID-19 in women are presented. The development and implementation of such a model can be carried out in 5 stages over 3 years: preparatory and analytical (1–2 quarters of the 1st year); creation and testing of a digital model (3–4 quarters of the 1st year); pilot implementation in the region (1–2 quarters of the 2nd year); scaling and integration (3–4 quarters of the 2nd year); effectiveness assessment and continuous improvement (3rd year and beyond). Model components: screening stage (at the primary level); prediction stage (secondary level); response stage (tertiary level); information support and monitoring. Conclusions. The practical implementation of the developed model allows improving the quality of medical care for pregnant women during the pandemic, optimizing the use of healthcare system resources, reducing the incidence of complications and improving perinatal outcomes even in conditions of limited resources. Актуальність. Актуальним є завдання розробки моделі прогнозування і профілактики несприятливих перинатальних наслідків у жінок із COVID-19, яка має забезпечити ефективне клінічне рішення з урахуванням індивідуальних та регіональних особливостей, що сприятиме зниженню материнської і перинатальної захворюваності та смертності. Мета. Створити інструмент для ранньої ідентифікації вагітних із високим ризиком ускладнень у разі COVID-19 для зниження материнської та перинатальної смертності, попередження несприятливих перинатальних ускладнень (на прикладі Івано-Франківської області). Матеріали та методи.Створення моделі прогнозування і профілактики несприятливих перинатальних наслідків при COVID-19 у жінки базується на проведених дослідженнях з використанням бібліосемантичного методу дослідження, метод структурно-логічного аналізу, аналітичний, статистичний та концептуальний методи, клінічні, анамнестичні та лабораторно-інструментальні методи, анкетування. Результати. Наведено медико-соціальне обґрунтування, принципи формування та очікувані результати впровадження моделі прогнозування і профілактики несприятливих перинатальних наслідків при COVID-19 у жінки. Розробка і впровадження такої моделі може здійснюватись у 5 етапів за 3 роки: підготовчо-аналітичний (1–2 квартал 1-го року); створення і тестування цифрової моделі (3–4 квартал 1-го року); пілотне впровадження в регіоні (1–2 квартал 2-го року); масштабування та інтеграція (3–4 квартал 2-го року); оцінка ефективності та постійне вдосконалення (3-й рік рік і далі). Компоненти моделі: етап скринінгу (на первинному рівні); етап прогнозування (вторинний рівень); етап реагування (третинний рівень); інформаційна підтримка та моніторинг. Висновки. Практичне впровадження розробленої моделі дозволяє покращити якість медичної допомоги вагітним у період пандемії, оптимізувати використання ресурсів системи охорони здоров’я, знизити частоту ускладнень та підвищити перинатальні результати навіть в умовах обмежених ресурсів.
- Open Access
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- No. 2,p. 55-59
LABORATORY MARKERS OF PERINATAL DISORDERS IN WOMEN WITH COVID-19
Introduction. There is insufficient data in the available literature on the association of laboratory changes in pregnant women with COVID-19, in particular coagulopathy indicators, with adverse pregnancy outcomes.The aim of the study is to identify potential laboratory markers of perinatal disorders in COVID-19 during pregnancy.Materials and methods. The comprehensive study included: 200 pregnant women who were hospitalized with COVID-19 during pregnancy (main group) and 50 patients who did not have COVID-19 during pregnancy (control group). The main group was divided into 2 subgroups: O1 – 50 women with adverse perinatal outcomes, O2 – 150 patients with a relatively favorable course of the gestational period.Complete blood count, biochemical indicators, and individual hemostasis parameters were taken into account.Study results. Potential risk factors for perinatal disorders in COVID-19 include anemia, thrombocytopenia, leukocytosis with increased rod-shaped neutrophils, increased liver transaminases, increased C-reactive protein, increased platelet aggregation, prothrombotic changes in hemostasis, in particular increased D-dimer, endothelial damage (increased von Willebrand factor). High activity of inflammatory processes in pregnant women with COVID-19 underlies systemic vasculitic changes and defects in blood coagulation processes, which cause damage to the maternal-fetal complex.Conclusions. It is important to monitor blood parameters in pregnant women with COVID-19 for timely detection of deterioration of the woman's condition and possible negative impact on perinatal outcomes. До потенційних факторів ризику перинатальних порушень за наявності COVID-19 можна віднести анемію, тромбоцитопенію, лейкоцитоз із підвищенням палочкоядкрних нейтрофілів, підвищення печінкових трансамфназ, зростання С-реактивного білка, зростання агрегації тромбоцитів, протромботичні зміни гемостазу, зокрема підвищення D-димеру, пошкодження ендотелію (зростання фактора фон Віллебранда). Висока активність запальних процесів у вагітних з COVID-19 лежить в основі системних васкулітних змін і дефектів процесів згортання крові, які обумовлюють пошкодження материнсько-плодового комплексу. У разі COVID-19 у вагітних важливо проводити моніторинг показників крові для своєчасного виявлення погіршення стану жінки й можливого негативного впливу на перинатальні наслідки.
- 1 January 2025
- Published by Publishing House Helvetica (Publications)
- No. 2,p. 55-59
Open AccessLABORATORY MARKERS OF PERINATAL DISORDERS IN WOMEN WITH COVID-19
Introduction. There is insufficient data in the available literature on the association of laboratory changes in pregnant women with COVID-19, in particular coagulopathy indicators, with adverse pregnancy outcomes.The aim of the study is to identify potential laboratory markers of perinatal disorders in COVID-19 during pregnancy.Materials and methods. The comprehensive study included: 200 pregnant women who were hospitalized with COVID-19 during pregnancy (main group) and 50 patients who did not have COVID-19 during pregnancy (control group). The main group was divided into 2 subgroups: O1 – 50 women with adverse perinatal outcomes, O2 – 150 patients with a relatively favorable course of the gestational period.Complete blood count, biochemical indicators, and individual hemostasis parameters were taken into account.Study results. Potential risk factors for perinatal disorders in COVID-19 include anemia, thrombocytopenia, leukocytosis with increased rod-shaped neutrophils, increased liver transaminases, increased C-reactive protein, increased platelet aggregation, prothrombotic changes in hemostasis, in particular increased D-dimer, endothelial damage (increased von Willebrand factor). High activity of inflammatory processes in pregnant women with COVID-19 underlies systemic vasculitic changes and defects in blood coagulation processes, which cause damage to the maternal-fetal complex.Conclusions. It is important to monitor blood parameters in pregnant women with COVID-19 for timely detection of deterioration of the woman's condition and possible negative impact on perinatal outcomes. До потенційних факторів ризику перинатальних порушень за наявності COVID-19 можна віднести анемію, тромбоцитопенію, лейкоцитоз із підвищенням палочкоядкрних нейтрофілів, підвищення печінкових трансамфназ, зростання С-реактивного білка, зростання агрегації тромбоцитів, протромботичні зміни гемостазу, зокрема підвищення D-димеру, пошкодження ендотелію (зростання фактора фон Віллебранда). Висока активність запальних процесів у вагітних з COVID-19 лежить в основі системних васкулітних змін і дефектів процесів згортання крові, які обумовлюють пошкодження материнсько-плодового комплексу. У разі COVID-19 у вагітних важливо проводити моніторинг показників крові для своєчасного виявлення погіршення стану жінки й можливого негативного впливу на перинатальні наслідки.
- Open Access
- 28 June 2024
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL HEALTH OF WOMAN
- No. 3(172),p. 4-11
Genetic-epigenetic aspects of infertility in women with long-COVID-19
The aim of the study is to determine the genetic and epigenetic features of infertile patients with long-term COVID-19 in order to clarify the risk factors for the failure of assisted reproductive technologies (ART) use. Materials and methods. The MTHFR (C677T, A1298С), RFC-1 (G80A) and BHMT (G742A) gene polymorphisms and the methylation of ESR1 gene was performed. 40 patients (main group) with infertility due to long-term COVID-19 were examined: the subgroup 1 - 25 women in whom the use of ART was ineffective, the subgroup 2 - 15 patients with effective use of ART. The control was taken from literary sources: for RFC (G80A), MTHFR (C677T) and MTHFR (A1298C) polymorphisms - 35 Ukrainian women without infertility and reproductive losses; for BHMT (G742A) - 60 people of the Ukrainian population. The methods of variational statistics were used, in particular the Fisher test with a significance level of p<0.05. Results. Patients of the main group have a higher frequency of the homozygous genotype of the MTHFR gene polymorphism (C677T) on the mutant T allele (20.0% vs. 3.2%; p<0.05). When ART is unsuccessful, the TT genotype is 4 times greater (28.0% vs. 6.7%; p<0.05). A study by genotypes of MTHFR polymorphism (A1298C) did not reveal a significant difference. Patients of the main group `have a higher frequency of the mutant allele A of the RFC gene (G80A) (80.0% vs. 51.4%; p<0.05). No significant difference was found depending on the success rate of ART. The frequency of BHMT gene polymorphism (G742A) in the main group did not differ from that in the Ukrainian population, however, in the case of unsuccessful ART, it was observed less often and only in the heterozygous variant (40.0% vs. 66.6%; p<0.05). The analysis of pairwise intergenic interaction revealed the highest frequency of the combination of AAGA for the MTHFR (A1298C)+BHMT (G742A) pair - 35.0% and GAAA for the RFC (G80A)+MTHFR (A1298C) pair - 30.0% in the main group. Hypermethylation of the promoter region of the ESR1 gene is observed in 20 (50.0%) patients of the main group: in 17 (68.0%) women of the subgroup 1 versus 3 (20.0%) women of the subgroup 2 (p<0.05). Conclusions. The genetic and epigenetic conditioning of the success of ART programs in infertility associated with long-term COVID-19 has been revealed, which opens up new diagnostic and therapeutic opportunities for identifying factors predisposing to unsuccessful ART treatment and increasing the effectiveness of such treatment by correcting disorders of folic acid metabolism, hyperhomocysteinemia and the estrogens receptor apparatus. The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of the institution mentioned in the work. Informed consent of the women was obtained for the research. The authors declare no conflict of interest.
- 28 June 2024
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL HEALTH OF WOMAN
- No. 3(172),p. 4-11
Open AccessGenetic-epigenetic aspects of infertility in women with long-COVID-19
The aim of the study is to determine the genetic and epigenetic features of infertile patients with long-term COVID-19 in order to clarify the risk factors for the failure of assisted reproductive technologies (ART) use. Materials and methods. The MTHFR (C677T, A1298С), RFC-1 (G80A) and BHMT (G742A) gene polymorphisms and the methylation of ESR1 gene was performed. 40 patients (main group) with infertility due to long-term COVID-19 were examined: the subgroup 1 - 25 women in whom the use of ART was ineffective, the subgroup 2 - 15 patients with effective use of ART. The control was taken from literary sources: for RFC (G80A), MTHFR (C677T) and MTHFR (A1298C) polymorphisms - 35 Ukrainian women without infertility and reproductive losses; for BHMT (G742A) - 60 people of the Ukrainian population. The methods of variational statistics were used, in particular the Fisher test with a significance level of p<0.05. Results. Patients of the main group have a higher frequency of the homozygous genotype of the MTHFR gene polymorphism (C677T) on the mutant T allele (20.0% vs. 3.2%; p<0.05). When ART is unsuccessful, the TT genotype is 4 times greater (28.0% vs. 6.7%; p<0.05). A study by genotypes of MTHFR polymorphism (A1298C) did not reveal a significant difference. Patients of the main group `have a higher frequency of the mutant allele A of the RFC gene (G80A) (80.0% vs. 51.4%; p<0.05). No significant difference was found depending on the success rate of ART. The frequency of BHMT gene polymorphism (G742A) in the main group did not differ from that in the Ukrainian population, however, in the case of unsuccessful ART, it was observed less often and only in the heterozygous variant (40.0% vs. 66.6%; p<0.05). The analysis of pairwise intergenic interaction revealed the highest frequency of the combination of AAGA for the MTHFR (A1298C)+BHMT (G742A) pair - 35.0% and GAAA for the RFC (G80A)+MTHFR (A1298C) pair - 30.0% in the main group. Hypermethylation of the promoter region of the ESR1 gene is observed in 20 (50.0%) patients of the main group: in 17 (68.0%) women of the subgroup 1 versus 3 (20.0%) women of the subgroup 2 (p<0.05). Conclusions. The genetic and epigenetic conditioning of the success of ART programs in infertility associated with long-term COVID-19 has been revealed, which opens up new diagnostic and therapeutic opportunities for identifying factors predisposing to unsuccessful ART treatment and increasing the effectiveness of such treatment by correcting disorders of folic acid metabolism, hyperhomocysteinemia and the estrogens receptor apparatus. The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of the institution mentioned in the work. Informed consent of the women was obtained for the research. The authors declare no conflict of interest.